School of Medicine
Showing 1-50 of 69 Results
-
Javier Ajenjo Barcenas
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioJavier received his MSci from the University Complutense in Madrid (Spain). He then moved to Prague (Czech Republic) where he earned his PhD degree in Chemistry from Univerzita Karlova under the supervision of Dr Petr Beier at IOCB, working on the synthesis and derivatization of hypervalent sulfur fluorides. During this period, he also took part as ESR of FLUOR21 initial training network led by Prof Graham Sandford (Durham University) and collaborated with F2 Chemicals Ltd. Later, he joined the University of Oxford (UK) as a postdoctoral research fellow to work on the synthesis and biological evaluation of F18-labeled ATM inhibitors under the supervision of Prof Bart Cornelissen. In 2021, he joined Ferrara lab as a postdoctoral scholar to work on the development of radiochemistry methods and the synthesis of therapeutics for medical imaging.
-
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, PET, Immuno-Oncology, Graft versus Host Disease, CAR T cells
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation with the motivation of developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response. She has also worked on several biomarker detection platforms for early disease detection. She is currently co-chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Visiting Researcher /Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Carolyn Bertozzi
Baker Family Director of Stanford ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology
BioProfessor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.
Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). She is now the Baker Family Director of Stanford ChEM-H.
Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, the ACS Award in Pure Chemistry, and the Chemistry of the Future Solvay Prize, among others.
The Bertozzi Group develops chemical tools to study the glycobiology underlying diseases such as cancer, inflammation, tuberculosis and most recently COVID-19. She is the inventor of "bioorthogonal chemistry", a class of chemical reactions compatible with living systems that enable molecular imaging and drug targeting. Her group also developed new therapeutic modalities for targeted degradation of extracellular biomolecules, such as antibody-enzyme conjugates and Lysosome Targeting Chimeras (LYTACs). As well, her group studies NGly1 deficiency, a rare genetic disease characterized by loss of the human N-glycanase.
Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi cofounded Redwood Bioscience, Enable Biosciences, Palleon Pharmaceuticals, InterVenn Bio, OliLux Bio, Grace Science LLC and Lycia Therapeutics. She is also a member of the Board of Directors of Lilly. -
Edwin Chang
Director, Small Animal Imaging Facility at Porter Drive, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector, SCI3@Porter or the Canary Core Preclinical Imaging Facility at Stanford
-
Jennifer Dionne
Associate Professor of Materials Science and Engineering, Senior Fellow at the Precourt Institute for Energy and Associate Professor, by courtesy, of Radiology
BioJennifer Dionne is the Senior Associate Vice Provost of Research Platforms/Shared Facilities and an Associate Professor of Materials Science and Engineering and of Radiology (by courtesy) at Stanford. Jen received her Ph.D. in Applied Physics at the California Institute of Technology, advised by Harry Atwater, and B.S. degrees in Physics and Systems & Electrical Engineering from Washington University in St. Louis. Prior to joining Stanford, she served as a postdoctoral researcher in Chemistry at Berkeley, advised by Paul Alivisatos. Jen's research develops nanophotonic methods to observe and control chemical and biological processes as they unfold with nanometer scale resolution, emphasizing critical challenges in global health and sustainability. Her work has been recognized with the Alan T. Waterman Award (2019), an NIH Director's New Innovator Award (2019), a Moore Inventor Fellowship (2017), the Materials Research Society Young Investigator Award (2017), Adolph Lomb Medal (2016), Sloan Foundation Fellowship (2015), and the Presidential Early Career Award for Scientists and Engineers (2014), and was featured on Oprah’s list of “50 Things that will make you say ‘Wow!'"
-
Gozde Durmus
Assistant Professor (Research) of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsDr. Durmus' research focuses on applying micro/nano-technologies to investigate cellular heterogeneity for single-cell analysis and personalized medicine. At Stanford, she is developing platform technologies for sorting and monitoring cells at the single-cell resolution. This magnetic levitation-based technology is used for wide range of applications in medicine, such as, label-free detection of circulating tumor cells (CTCs) from blood; high-throughput drug screening; and rapid detection and monitoring of antibiotic resistance in real-time. During her PhD, she has engineered nanoparticles and nanostructured surfaces to decrease antibiotic-resistant infections.
-
Katherine Ferrara
Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsMy focus is image-guided drug and gene delivery and I am engaged in the design of imaging devices, molecularly-targeted imaging probes and engineered delivery vehicles, drawing upon my education in biology and imaging physics and more than 20 years of experience with the synthesis and labeling of therapeutic particles. My laboratory has unique resources for and substantial experience in synthetic chemistry and ultrasound, CT, MR and PET imaging.
-
Edward Graves
Associate Professor of Radiation Oncology (Radiation Physics) and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, development of hypoxia and radiosensitivity imaging techniques, small animal image-guided conformal radiotherapy, image processing and analysis.
-
Thomas Guenther
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsCurrent research projects include the development of:
1) Gastrin-releasing peptide receptor (GRPR) targeted radiotheranostics (Cu-64, Ga-68, Tb-161, Lu-177, amongst others)
2) Radiohybrid-based cholecystokinin-2 receptor (CCK-2R) targeted radiotheranostics (F-18, Lu-177)
3) Radiotherapeutics for targeted alpha-particle therapy
4) Radiotheranostics for novel targets
All projects have a strong focus on clinical translation -
Frezghi Habte
Director, Stanford Center for Innovations in In vivo Imaging (SCi3), Stanford Center for Innovation and In Vivo Imaging
Current Role at StanfordDirector, Stanford Center for Innovation, in In vivo Imaging
-
Ka Chun Ho
Lab Assistant I, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordLab Assistant I - Stanford University, Cyclotron & Radiochemistry Facility
-
Mojtaba Jafaritadi
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsDr. Jafaritadi is working on signal processing and machine learning applications in cancer, cardiac, and brain PET imaging. His research focuses on generative AI for image correction, image-to-image translation, and image denoising. He is also interested in working on data- and device-driven motion tracking and correction systems for PET imaging using deep neural networks.
-
Michelle L. James
Assistant Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology
Instructor, Radiology- Molecular Imaging Program at StanfordCurrent Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioJeff is an Adjunct Professor at Stanford University and a leader in the Silicon Valley tech venture community. He is an established technology and software entrepreneur who has built several ventures from concept to market leader. Jeff has served as Founder, CEO, and Chairman, and has taken his ventures public on the NASDAQ and unified them into far-reaching commercial corporations.
Jeff is a Partner of Elevens, a strategic advisory designed to harness some of the foremost AI minds on the planet to accelerate breakthrough ventures in health-tech, med-tech, bio-tech, and pharma-tech. Elevens is based in Silicon Valley and can be found at www.elevens.ai.
Jeff currently serves as a Special Government Expert (SGE) to the United States Government, acting as a Special Advisor to the Department of Defense. His role entails the identification and delivery of advanced technology for national security. In the past, Jeff has also served as a Highly Qualified Expert (HQE) in the Senior Executive Service for the United States Government. During this time, he held the position of Director, responsible for delivering transformational and strategic capabilities to enhance national security by promoting the adoption of innovative and commercial technologies.
Jeff has participated as a visiting scientist at two national laboratories, including Lawrence Berkeley National Laboratory and Los Alamos National Laboratory, and as an Adjunct Professor at the University of California Los Angeles (UCLA).
Jeff is formally educated in several engineering, medical applied science, and technology disciplines, and holds a PhD in Biomedical Physics from UCLA, an MS in Engineering Management from Stanford University, an MS in Nuclear Engineering from Texas A&M University, and a BS in Nuclear Engineering from Texas A&M University.
The industry profile for Jeff can be found at www.linkedin.com/in/jeff-kleck-a000299/ and the commercial profile for Elevens can be found at https://www.linkedin.com/company/82564221/ -
Jason Thanh Lee
Deputy Director, Molecular Imaging Program, Rad/Molecular Imaging Program at Stanford
BioBiomedical imaging scientist in preclinical molecular and nuclear imaging, particularly employing PET, CT and optical techniques. Applications include therapeutic development, oncology, immunotherapy, neuroscience, and molecular biology. Active in translational diagnostics research and development. Lead a scientific team and skilled in project management with a portfolio of academic and pharmaceutical/biotechnology partners. Broad foundation in molecular biology assays and in vivo disease models.
-
Craig Levin
Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsMolecular Imaging Instrumentation
Laboratory
Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects. -
Ning Lu
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioNing Lu received a joint Ph.D. degree in Biomedical Engineering and Scientific Computing from the University of Michigan, Ann Arbor, USA, in 2023. Previously, she earned a B.S.E. degree (highest honors) in Biomedical Engineering from Southeast University, Nanjing, China, in 2018. From May 2022 to September 2022, she worked at Meta (formerly Facebook) Reality Labs as a research scientist intern on ultrasonic eye tracking for AR/VR wearable devices, in Redmond, Washington, USA. Her research interests include ultrasound instrumentation, ultrasound therapy, ultrasound imaging algorithms, and AI in healthcare.
-
Rim Malek
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsMy work is focused on the development of small molecules radiotracers for cancer imaging, and small molecules and peptides theranostics for cancer detection, targeted radionuclide therapy, and monitoring of tumor response to therapy.
-
Noeen Malik, PhD
Lead Radiochemist, R & D Scientist Engineer II, Cyclotron & Radiochem. Facility, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordLead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/ -
Sydney Clara Nagy
Temp - Non-Exempt, Rad/Molecular Imaging Program at Stanford
BioWebsite: https://sydneycnagy.wixsite.com/sydneyclaranagy
IMDb: https://www.imdb.com/name/nm10012799 -
Arutselvan Natarajan
Senior Research Scientist - Basic Life, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Scientist
-
Sanaz Nazari Farsani
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioDr. Nazari Farsani works on developing and implementing machine learning techniques for automated tissue segmentation from brain PET/MR images. She is also developing machine learning algorithms for PET data correction and de-noising.
-
Chirag Patel, MD, PhD
Clinical Assistant Professor, Radiology - Rad/Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsNeuro-oncology, Clinical Trials, Tumor Treating Fields (TTFields), Molecular/PET Imaging, Neuroimaging, Immunotherapy, Big Data Analysis
-
Shirin Pourashraf
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsMy working is focused on building a 100 ps CTR pre-clinical partial ring TOF-PET scanner; specifically, by exploring, and designing high speed low noise/jitter instrumentation, and data acquisition.
I am also designing an scalable side-readout electronic to detect Cherenkov radiation and improve TOF resolution in PET detectors using BGO crystals.
